Skip to main content
SLAS Europe 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Tony B Awardee
Tony B Awardee
Food/Beverage Available
Food/Beverage Available
Data Science and AI Parallel Path
Data Science and AI Parallel Path
Lab Automation Parallel Path
Lab Automation Parallel Path
Back

Enrique Hernández Jiménez, PhD

CEO & CSO
Loop Diagnostics S.L.
Barcelona, Catalonia, Spain

Enrique Hernández Jiménez, born in Soria, Spain in 1989, embarked on his scientific journey by relocating to Lleida for a Biotechnology degree. His passion for science flourished during a transformative internship in the United States and was further enriched through an Erasmus study program in Florence, where he specialized in the biomedical field. Completing his Ph.D. at La Paz Hospital in Madrid, Enrique explored the reprogramming of the immune response in infectious diseases, notably sepsis, and authored over 25 papers in less than five years. Standouts include ERJ 2017 (first author), JCI 2016 (second author), and JID 2017 (last author).

Enrique successfully completed the d•HEALTH Barcelona program, gaining profound insights into biomedical innovation. He adeptly mastered Biodesign for identifying and implementing healthcare solutions, Lean start-up principles for customer-centric business validation, and Creative leadership to foster business creativity and leadership. With a vision to translate research into market solutions addressing clinical needs, Enrique served as a post-doc at Bellvitge Hospital from September 2018 to February 2020. There, he significantly contributed to the translational use of RANK inhibitors, establishing biological platforms for testing future therapeutic molecules. Subsequently, he worked as an entrepreneur in residence in the Innate Immunity and Pathology of the Critical Patient group, patenting technology for immune system analysis.

Currently, Enrique leads Loop Diagnostics S.L. as CEO, managing an innovative microbiological diagnostic startup dedicated to creating the first rapid test that identifies bacterial infections in the blood through immune activity. This diagnostic device proves invaluable for emergency physicians, aiding in informed clinical decisions, especially in managing sepsis infections. Through his diverse experiences, Enrique seamlessly integrates scientific expertise, entrepreneurial spirit, and a commitment to creating impactful solutions for healthcare challenges.

Disclosure information not submitted.

Presentation(s):